Cited by 116Diabetes Management and ResearchDiabetes Treatment and ManagementDiabetes Management and Education

Randomized trial of a dual‐hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor‐augmented pump therapy

Open access
Jacobs, P. G., El Youssef, J., Reddy, R., Resalat, N., Branigan, D., Condon, J., Preiser, N., Ramsey, K. +6 more·2016·Diabetes, Obesity and Metabolism

Abstract

Aims: To test whether adjusting insulin and glucagon in response to exercise within a dual‐hormone artificial pancreas ( AP ) reduces exercise‐related hypoglycaemia. Materials and methods: In random order, 21 adults with type 1 diabetes ( T1D ) underwent three 22‐hour experimental sessions: AP with exercise dosing adjustment ( APX ); AP with no exercise dosing adjustment ( APN ); and sensor‐augmented pump ( SAP ) therapy. After an overnight stay and 2 hours after breakfast, participants exercised for 45 minutes at 60% of their maximum heart rate, with no snack given before exercise. During APX , insulin was decreased and glucagon was increased at exercise onset, while during SAP therapy, subjects could adjust dosing before exercise. The two primary outcomes were percentage of time spent in hypoglycaemia (<3.9 mmol/ L ) and percentage of time spent in euglycaemia (3.9‐10 mmol/ L ) from the start of exercise to the end of the study. Results: The mean (95% confidence interval) times spent in hypoglycaemia (<3.9 mmol/ L ) after the start of exercise were 0.3% (−0.1, 0.7) for APX , 3.1% (0.8, 5.3) for APN , and 0.8% (0.1, 1.4) for SAP therapy. There was an absolute difference of 2.8% less time spent in hypoglycaemia for APX versus APN (p = .001) and 0.5% less time spent in hypoglycaemia for APX versus SAP therapy (p = .16). Mean time spent in euglycaemia was similar across the different sessions. Conclusions: Adjusting insulin and glucagon delivery at exercise onset within a dual‐hormone AP significantly reduces hypoglycaemia compared with no adjustment and performs similarly to SAP therapy when insulin is adjusted before exercise.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12707

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [20]Pescatello LS American College of Sports Medicine Guidelines for Exercise Testing and Prescription 9 Philadelphia Wolters Kluwer/Lippincott Williams & Wilkins Health 2014

Cited by

Sorted by citations

Authors
Jacobs, P. G., El Youssef, J., Reddy, R., Resalat, N., Branigan, D., Condon, J., Preiser, N., Ramsey, K., Jones, M., Edwards, C., Kuehl, K., Leitschuh, J., Rajhbeharrysingh, U., & Castle, J. R.
Affiliations
  • Oregon Health & Science University (US)
  • Department of Medicine, Division of Endocrinology, Harold Schnitzer Diabetes Health Center Oregon Health and Science University Portland
Corresponding author
Jacobs, P. G.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2016-08-15
Volume
18
Issue
11
Pages
1110-1119
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2463876450
Cited by
116
References
23
Citations by year
2026: 1 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 11 · 2021: 11 · 2020: 16 · 2019: 25 · 2018: 20 · 2017: 10 · 2016: 3
FWCI
19.41
Type
journal article
Language
en
Open access
Locations
  • Diabetes Obesity and Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
Oregon Clinical and Translational Research Institute (UL1TR000128)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
type 1 diabetes, exercise-induced hypoglycaemia, sensor-augmented pump therapy, continuous glucose monitoring
MeSH terms
Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Dose-Response Relationship, Drug, Female, Glucagon, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Middle Aged, Biosensing Techniques, Exercise, Cross-Over Studies, Pancreas, Artificial, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review